tiprankstipranks
Immunicum AB (DE:1YG0)
FRANKFURT:1YG0
Germany Market

Immunicum AB (1YG0) Cash flow

1 Followers

Immunicum AB Cash Flow

DE:1YG0's free cash flow for Q3 2022 was kr-27.82M. For the 2022 fiscal year, DE:1YG0's free cash flow was decreased by kr-82.30M and operating cash flow was kr-27.82M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
kr -113.61Mkr -138.03Mkr -56.63Mkr -57.57Mkr -104.67Mkr -46.45M
Investing Cash Flow
kr -10.44Mkr -1.36Mkr 157.30Mkr -809.00Kkr 0.00kr 10.16M
Financing Cash Flow
kr -2.48Mkr 127.03Mkr 50.90Mkr 67.06Mkr 419.58Mkr 62.27M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 418.50Mkr 155.31Mkr 167.64Mkr 14.03Mkr 443.80Mkr 128.88M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-kr 141.24Mkr 53.68Mkr 67.82Mkr 456.28Mkr 94.76M
Issuance Of Debt
kr 1.57Mkr 0.00kr 3.80Mkr 0.00--
Repayment Of Debt
kr -4.05Mkr -1.92Mkr -4.52Mkr -760.00K--
Free Cash Flow
kr -125.61Mkr -139.39Mkr -57.09Mkr -58.38Mkr -104.67Mkr -46.45M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

Immunicum AB Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis